# A Clinical Study Evaluating the Safety and Efficacy of SI-614 Ophthalmic Solution in Patients With Dry Eye.

> **NCT02205840** · PHASE2,PHASE3 · COMPLETED · sponsor: **Seikagaku Corporation** · enrollment: 240 (actual)

## Conditions studied

- Dry Eye Syndromes

## Interventions

- **DRUG:** SI-614
- **DRUG:** Vehicle

## Key facts

- **NCT ID:** NCT02205840
- **Lead sponsor:** Seikagaku Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-07
- **Primary completion:** 2014-11
- **Final completion:** —
- **Target enrollment:** 240 (ACTUAL)
- **Last updated:** 2023-07-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02205840

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02205840, "A Clinical Study Evaluating the Safety and Efficacy of SI-614 Ophthalmic Solution in Patients With Dry Eye.". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02205840. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*